Search Results - DosReis, Ana Filipa Palma

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL

    A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL by Collins, Graham P., Townsend, William, Abdulgawad, Ahmed, Namburi, Swathi, Williams, Anja, DosReis, Ana Filipa Palma, Krebs, Matthew G., Evans, Jeff, Blagden, Sarah P., Plummer, Ruth, Hochhauser, Daniel, Sharp, Adam, Cole, George, Rogers, Seema, Chan, Daniel, Whelan, Sarah, El-Sharkawi, Dima

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Abstract B044: Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors

    Abstract B044: Results of a phase 1 dose escalation clinical trial of NXP800, a novel GCN2 activator, in patients with advanced or metastatic solid tumors by Banerji, Udai, Pacey, Simon, Finkelstein, Karen, Rodney, Simon, DosReis, Ana Filipa Palma, Codaccipisanelli, Giovanni, Sloan, Mark, Raynaud, Florence I, Ruddle, Ruth, Swales, Karen, Tall, Matthew, Shemesh, Shay, Marsolini, Diane, Sardone, Megan, Hay, Justin, Bliss, Robin, Poradosu, Enrique, Workman, Paul

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: